Affordable Access

Alendronate treatment does not inhibit bone formation within biphasic calcium phosphate ceramics in posterolateral spinal fusion: an experimental study in porcine model.

Authors
Type
Published Article
Journal
Chinese medical journal
Publication Date
Volume
122
Issue
22
Pages
2770–2774
Identifiers
PMID: 19951612
Source
Medline
License
Unknown

Abstract

Oral alendronate with a dose of 10 mg daily do not inhibit bone formation within BCP ceramics or affect the fusion rate in posterolateral spinal fusion from porcine models.

Statistics

Seen <100 times